Institut Für Klinische Krebsforschung Ikf Gmbh At Krankenhaus Nordwest

This study tests a new two-drug combination (enfortumab vedotin plus avelumab) as a first treatment for men with advanced or metastatic penile cancer that cannot be cured by surgery. The goal is to see if the drugs can shrink tumors and help patients live longer. The trial enroll…

This study is for people with advanced liver cancer who are starting a combination of two drugs (atezolizumab and bevacizumab). It will test if adding a procedure called TIPS, which places a small tube in the liver to improve blood flow, can help keep the liver working better for…

This study tests the drug cemiplimab as a first treatment for people with advanced basal cell carcinoma who have not received prior therapy. About 34 participants will receive the drug to see if it shrinks tumors and how safe it is. The goal is to find a new option for this type …